eBook | Adoptive cell therapies: advancing cancer treatment for solid tumors
Download peer-reviewed content and expert insights in our latest eBook.
Adoptive cell therapy harnesses engineered immune cells to target and eliminate cancer. While this approach has already revolutionized treatment for hematopoietic cancers, its effectiveness in solid tumors remains a significant challenge. The hostile tumor microenvironment in solid tumors poses barriers to success, including suppressive signals, physical obstacles and limited immune cell access. However, recent advancements in gene editing, human leukocyte antigen (HLA) typing, and biomarker identification are reshaping the way adoptive cell therapies are developed and applied in cancer treatment.
This eBook features a curated collection of articles that explore how these advancements are enhancing the fight against cancer, making therapies safer, more effective and increasingly personalized. Together, these insights provide a comprehensive overview of the current state of the field and its promising future directions.
- [INTERVIEW] Therapeutic hurdles in solid tumor management and the promise of adoptive cell approaches: an interview with Leonardo Ferreira
- [CANCER MEDIA TOOLBOX] Demystify the complexity of cancer research
- [OPINION] CAR-T therapies: a breakdown of key developments for mesothelioma, lymphoma and solid tumors
- [REVIEW] Pitfalls and strategies of CAR-T therapy in solid tumors and implications for chordoma treatment
- [WHITE PAPER] Human leukocyte antigen: the importance of HLA for the development of cell therapies
- [NEWS] Unlocking the anti-tumor potential of CD4 T cells
- [REVIEW] Advances in tumor immunotherapy targeting macrophages
- [APPLICATION NOTE] Isolation of tumor associated macrophages (TAM) from fresh tumor tissue
